May 11, 2012
1 min read
Save
Behind the Lab Door
News from retina research laboratories across the country.
Click here to see this months studies.
Randomized, Multi-center, Phase 2 Study of the Safety, Tolerability
and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy
or in Combination with Ranibizumab or Laser Photocoagulation in the Treatment
of Diabetic Macular Edema with Involvement of the FoveAL Center (the iDEAL
Study)
Wilmer Eye Institute at Johns Hopkins
Intravitreal Ketorolac for Chronic Uveitis: A Phase 1 Investigational
Safety Study (INCITE)
Vanderbilt Eye Institute